- Home
- BCRX vs PINC Comparison
BCRX vs PINC Comparison
Compare BCRX & PINC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCRX
- PINC
- Stock Information
- Founded
- BCRX 1986
- PINC 2013
- Country
- BCRX United States
- PINC United States
- Employees
- BCRX N/A
- PINC N/A
- Industry
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- PINC Other Consumer Services
- Sector
- BCRX Health Care
- PINC Consumer Discretionary
- Exchange
- BCRX Nasdaq
- PINC Nasdaq
- Market Cap
- BCRX 1.7B
- PINC 1.8B
- IPO Year
- BCRX 1994
- PINC 2013
- Fundamental
- Price
- BCRX $10.75
- PINC $22.98
- Analyst Decision
- BCRX Buy
- PINC Hold
- Analyst Count
- BCRX 8
- PINC 6
- Target Price
- BCRX $16.75
- PINC $22.20
- AVG Volume (30 Days)
- BCRX 6.8M
- PINC 1.8M
- Earning Date
- BCRX 05-05-2025
- PINC 05-06-2025
- Dividend Yield
- BCRX N/A
- PINC 3.66%
- EPS Growth
- BCRX N/A
- PINC N/A
- EPS
- BCRX N/A
- PINC 0.63
- Revenue
- BCRX $503,485,000.00
- PINC $1,260,388,000.00
- Revenue This Year
- BCRX $36.61
- PINC N/A
- Revenue Next Year
- BCRX $13.19
- PINC N/A
- P/E Ratio
- BCRX N/A
- PINC $21.08
- Revenue Growth
- BCRX 41.67
- PINC 7.16
- 52 Week Low
- BCRX $5.92
- PINC $17.23
- 52 Week High
- BCRX $11.11
- PINC $23.56
- Technical
- Relative Strength Index (RSI)
- BCRX 64.20
- PINC 68.48
- Support Level
- BCRX $10.46
- PINC $22.63
- Resistance Level
- BCRX $11.00
- PINC $23.40
- Average True Range (ATR)
- BCRX 0.41
- PINC 0.47
- MACD
- BCRX -0.02
- PINC -0.12
- Stochastic Oscillator
- BCRX 77.78
- PINC 63.48
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
About PINC Premier Inc.
Premier Inc is a Charlotte, North Carolina-based technology-driven healthcare improvement company, uniting an alliance of United States (U.S.) hospitals, health systems, and other providers and organizations to transform healthcare. The company's revenue is all sourced domestically and is reported in two business segments: the supply chain services and the consulting and technology platform of performance services. It generates the majority of its revenue from the supply chain services segment.